Advertisement

Topics

Teva Announces Prescription Copay Savings Program for Generic Gleevec® Tablets in the United States

14:19 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
People who meet certain requirements are eligible to participate and may pay as little as $0 out-of-pocket Teva Pharmaceuticals USA, a subsidiary of Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced ...

Other Sources for this Article

Teva Pharmaceuticals USA, Inc.
PR Contacts:
United States
Denise Bradley, 215-591-8974
or
Elizabeth DeLuca, 484-612-5407

NEXT ARTICLE

More From BioPortfolio on "Teva Announces Prescription Copay Savings Program for Generic Gleevec® Tablets in the United States"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...